BP has led a task force to gain UK Ministry of Defense approval to allow co-processing of sustainable aviation fuel (SAF) with up to 30% renewable hydroprocessed esters and fatty acids, up from 5%. The updated Defence Standard, approved globally for Jet A1 fuel production, enables BP and other producers to increase SAF output using existing refinery assets.

Scaling up solar energy generation by 15% could reduce US carbon dioxide emissions by 8.54 million metric tons per year. As the future of the Environmental Protection Agency's legal authority to regulate emissions appears uncertain, new research finds that this 15% growth rate, which is in line with current trends, would account for 12% of the cuts needed to reduce carbon dioxide emissions from power plants by 1,380 million m.t. by 2042.

Low-emission hydrogen production is expected to increase significantly by 2030 amid falling costs, despite delays and cancellations, reports the International Energy Agency. Global hydrogen demand hit nearly 100 million metric tons in 2024, primarily met by fossil fuel-based hydrogen. China leads in electrolyzer deployment, and Southeast Asia is emerging as a hydrogen market.

ExxonMobil has acquired a battery materials factory in Kentucky and research facilities in Illinois from Superior Graphite as part of a strategy to become a major supplier of lithium and graphite for electric vehicle batteries by the end of the decade. It plans to begin commercial production of synthetic graphite at the Kentucky facility in 2029.

Eli Lilly and Co. has introduced Lilly TuneLab, an AI platform that provides early-stage biotechs access to drug discovery models developed from years of Lilly's research data. The platform uses federated learning, allowing companies to benefit from AI models without direct data sharing.

VedaBio has entered a non-exclusive licensing agreement with Mammoth Biosciences to improve its CRISPR-based molecular detection platform. The deal gives VedaBio access to essential CRISPR intellectual property to use in the development of customized diagnostic solutions.

Smart textiles are being developed for automated glucose monitoring, potentially advancing diabetes care by integrating data collection into everyday garments that transmit the data to electronic health records (EHRs). Researchers at Penn State University are developing graphene-based sensors that can detect glucose levels in sweat with 91% sensitivity over three weeks, according to a study in Advanced Functional Materials. "I think smart textiles could reduce diabetes burnout for patients by making glucose monitoring more seamless and less intrusive," said endocrinologist Disha Narang.

Regeneron Pharmaceuticals reported that five-year data from a Phase 3 trial shows that Libtayo, or cemiplimab, plus chemotherapy provided an overall survival rate of 19.4% compared with 8.8% for chemotherapy alone in patients with non-small cell lung cancer. The findings were reported in the Journal of Clinical Oncology.

Innovative vaccine strategies are underway to combat malaria, including Sanaria's whole-parasite vaccine, PfSPZ-LARC2, which aims to provide high-level protection. This vaccine utilizes genetically modified parasites to elicit a broader immune response, offering up to 90% protection against infection.

The Trump administration's latest "Make America Healthy Again" report, led by HHS Secretary Robert F. Kennedy Jr., calls for more rigorous investigations into vaccine injuries and the causes of autism. The report has sparked controversy due to Kennedy's anti-vaccine stance, with bipartisan senators expressing concerns about the impact on public health. The report also addresses issues like prescription drug use and ultraprocessed food but lacks detailed regulatory plans.